Mutual of America Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,400
Closed -$28K 1645
2021
Q4
$28K Buy
22,400
+516
+2% +$923 ﹤0.01% 1635
2021
Q3
$48K Sell
21,884
-1,079
-5% -$2.95K ﹤0.01% 1623
2021
Q2
$86K Buy
22,963
+3,475
+18% +$12.1K ﹤0.01% 1590
2021
Q1
$64K Buy
19,488
+1,187
+6% +$4.25K ﹤0.01% 1616
2020
Q4
$62K Buy
18,301
+812
+5% +$3.34K ﹤0.01% 1580
2020
Q3
$71K Buy
17,489
+11,848
+210% +$45K ﹤0.01% 1475
2020
Q2
$19K Buy
5,641
+732
+15% +$2.13K ﹤0.01% 1562
2020
Q1
$11K Buy
4,909
+997
+25% +$2.73K ﹤0.01% 1593
2019
Q4
$14K Sell
3,912
-223
-5% -$1.8K ﹤0.01% 1623
2019
Q3
$34K Buy
4,135
+326
+9% +$2.64K ﹤0.01% 1447
2019
Q2
$33K Buy
3,809
+801
+27% +$7.17K ﹤0.01% 1451
2019
Q1
$32K Buy
3,008
+527
+21% +$5.64K ﹤0.01% 1412
2018
Q4
$22K Buy
2,481
+594
+31% +$7.57K ﹤0.01% 1449
2018
Q3
$32K Buy
1,887
+1,543
+449% +$33.4K ﹤0.01% 1349
2018
Q2
$7K Buy
+344
New +$6.37K ﹤0.01% 1318

Other funds holding SPPI

Mutual of America Capital Management's SPPI Position: Q1 2022 in Review

Mutual of America Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 22,400 shares — an estimated $28K sold.

Mutual of America Capital Management first reported a position in SPPI in Q2 2018 and held it in 15 quarters. The position peaked at $86K in Q2 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Mutual of America Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 22,400 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $28K.
  • Mutual of America Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 15 quarters.
  • Mutual of America Capital Management's Spectrum Pharmaceuticals Inc position peaked at $86K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Mutual of America Capital Management's 13F filing for Q1 2022, filed 2 May 2022.